NCT02770222 - A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Healthy Subjects

Interventions

DRUG

Selexipag

Two selexipag film-coated tablets of 200 µg as single oral dose (total dose = 400 µg)

DRUG

Gemfibrozil

Gemfibrozil film-coated tablet of 600 mg administered orally b.i.d. from Day 1 to Day 9

DRUG

Rifampicin

Rifampicin film-coated tablet of 600 mg administered orally o.d.from Day 1 to Day 9